NCT03923270 2026-04-01Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Active not recruiting25 enrolled